Table 2.

Treatment-related adverse events

Adverse Event	All Grades, N=28,n (%)*	Grade 3/4, N=28,n (%)
Anemia	20 (71)	5 (18)
Hyperglycemia	20 (71)	4 (14)
Hypoalbuminemia	19 (68)	1 (4)
Hypophosphatemia	17 (61)	6 (21)
Increased alanine aminotransferase	16 (57)	1 (4)
Decreased white blood cells	15 (54)	2 (7)
Hypomagnesemia	14 (50)	0
Decreased platelets	13 (46)	3 (11)
Increased alkaline phosphatase	12 (43)	1 (4)
Increased aspartate aminotransferase	11 (39)	1 (4)
Decreased lymphocytes	11 (39)	10 (36)
Nausea	11 (39)	2 (7)
Hypocalcemia	9 (32)	2 (7)
Hypokalemia	9 (32)	5 (18)
Constipation	8 (29)	0
Hyponatremia	8 (29)	4 (14)
Increased creatinine	6 (21)	0
Fatigue	6 (21)	0

^*All-grade adverse events occurring in ≥20% of patients